A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Phase 1 Unknown
77 enrolled
MK-3475-E90
Phase 1 Unknown
54 enrolled
Safety/Tolerability, PK and Efficacy of IMB071703 Injection in Patients With Advanced Solid Tumors
Phase 1 Unknown
93 enrolled
Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies
Phase 1 Unknown
499 enrolled
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors
Phase 1 Unknown
36 enrolled
Intratumoral CAN1012(Selective TLR7 Agonist) in Subjects With Solid Tumors
Phase 1 Unknown
36 enrolled
Clinical Study of SM3321 With Solid Tumors
Phase 1 Unknown
48 enrolled
Study of BEBT-607 Tablets in The Treatment of Advanced or Metastatic Solid Tumors With KRAS G12C Mutation
Phase 1 Unknown
126 enrolled
Minnelide 101
Phase 1 Unknown
66 enrolled
Clinical Study of CD70-targeted CAR-T Therapy for Advanced/Advanced Renal Cancer
Phase 1 Unknown
24 enrolled
A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors
Phase 1 Unknown
36 enrolled
A Clinical Research About CD70-positive Advanced/Metastatic Solid Tumors Treated by CD70-targeted CAR-T
Phase 1 Unknown
48 enrolled
HM95573 in Combination With Either Cobimetinib or Cetuximab in Patients With Locally Advanced or Metastatic Solid Tumors
Phase 1 Unknown
148 enrolled
A Study of TY-2136b in Patients With Advanced Solid Tumors Harboring ALK, ROS1 or NTRK1-3 Alterations
Phase 1 Unknown
282 enrolled
Determine Safety & Recommended Phase 2 Dosing of Zeaxanthin Alone or in Combination w/Pembrolizumab in Patients With Metastatic Cancer
Phase 1 Unknown
72 enrolled
The Clinical Trial to Evaluate the Pharmacokinetics and Safety of MRTX849 in Patients With Advanced Solid Tumors
Phase 1 Unknown
22 enrolled
SHR-1701 in Subjects With Metastatic or Locally Advanced Solid Tumors
Phase 1 Unknown
193 enrolled
Phase I Study of SHR9146 + SHR-1210 +/- Apatinib in Patients With Advanced Solid Tumors
Phase 1 Unknown
23 enrolled
A Study to Assess PV-10 Chemoablation of Cancer of the Liver
Phase 1 Unknown
78 enrolled
Safety and Preliminary Efficacy of BNA035 in Patients With Advanced Solid Tumors
Phase 1 Unknown
48 enrolled
A Phase I Study of WM-S1-030 in Patients With Advanced Solid Tumors
Phase 1 Unknown
100 enrolled
A Study of RX108 in Patients With Locally Advanced or Metastatic Solid Tumors
Phase 1 Unknown
80 enrolled
A Phase 1,Open-label Study of BPI-421286 in Subjects With Advanced Solid Tumors
Phase 1 Unknown
80 enrolled
A Trial of HRS-8080 Tablets in Metastatic or Local Advanced Breast Cancer of Adults
Phase 1 Unknown
156 enrolled
Study of TJ004309 in Combination With Atezolizumab (Tecentriq®) in Patients With Advanced or Metastatic Cancer
Phase 1 Unknown
36 enrolled
A Phase 1 Study of BPI-28592 in Subjects With Advanced Solid Tumors
Phase 1 Unknown
40 enrolled
Safety,Tolerability,and Efficacy of VCN-01 With Durvalumab in R/M Head and Neck Squamous Cell Carcinoma
Phase 1 Unknown
20 enrolled
Single Arm Phase I Trail of Autologous Tumor Infiltrating Lymphocyte Injection (GT202) in the Treatment of Metastatic or Recurrent Gynecological Tumors
Phase 1 Unknown
36 enrolled
A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK114
Phase 1 Unknown
30 enrolled
Study of MTB-9655, an Inhibitor of ACSS2, in Patients With Advanced Solid Tumors
Phase 1 Unknown
30 enrolled
SHR-1701 in Metastatic or Locally Advanced Solid Tumors
Phase 1 Unknown
206 enrolled
A Study of MPT-0118 in Subjects With Advanced or Metastatic Refractory Solid Tumors
Phase 1 Unknown
70 enrolled
ATRiUM
Phase 1 Unknown
55 enrolled
i-GO
Phase 1 Unknown
12 enrolled
Phase 1 Study of HLX10, a Monoclonal Antibody Targeting Programmed Death-1 (PD-1) in Patients With Advanced Solid Tumors
Phase 1 Unknown
30 enrolled
A Personalized NeoAntigen Cancer Vaccine Combined With Anti-PD-1 in Melanoma
Phase 1 Unknown
30 enrolled
Study of Alofanib in Patients With Metastatic Gastric Cancer
Phase 1 Unknown
50 enrolled
Phase I Trial of LMP2 Antigen-specific TCR T-cell Therapy for Recurrent and Metastatic NPC Patients
Phase 1 Unknown
27 enrolled
A Safety Study of the Pan-immunotherapy in Patients With Unresectable/Metastatic Solid Tumors or Lymphomas
Phase 1 Unknown
20 enrolled
Intraperitoneal Infusion of EpCAM CAR-T Cell in Advanced Gastric Cancer With Peritoneal Metastasis (WCH-GC-CART)
Phase 1 Unknown
40 enrolled
Safety and Pharmacokinetic Study of MM-302 in Patients With Advanced Breast Cancer
Phase 1 Unknown
75 enrolled
Dendritic Killer Cell-based Immunotherapy for Solid Tumors
Phase 1 Unknown
18 enrolled
Safety Study of GC1118 (Recombinant Human Anti-EGFR Antibody) in Patients With Advanced Solid Cancer
Phase 1 Unknown
72 enrolled
Study of Cytolytic Viral Activation Therapy (CVAT) for Recurrent/Metastatic Nasopharyngeal Carcinoma
Phase 1 Unknown
18 enrolled
Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors
Phase 1 Unknown
45 enrolled
Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors
Phase 1 Unknown
24 enrolled
EVESOR
Phase 1 Unknown
60 enrolled
TIROX
Phase 1 Unknown
23 enrolled
Chemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
Phase 1 Unknown
45 enrolled
Study of 111In-DAC as an Medical Imaging Agent for Lung Cancer and Brain Cancer Consistent With Metastatic Lung Cancer
Phase 1 Unknown